Back to results
US 2025/0026731 A1Published application
Prodrugs of mdma, mda, and derivatives thereof
AssigneeEmpathBio, Inc.
InventorsSrinivas RAO, Glenn SHORT, Robert B. PERNI, Tanweer A. KHAN, Alan C. GIBBS
Life of this patent
Estimating the term…
Abstract
The present disclosure provides prodrug compounds of MDMA, MDA, and derivatives thereof having an improved pharmacokinetic profile suitable for the treatment of various neurological diseases.
Claims34
A compound of Formula (I):
- or a pharmaceutically acceptable salt thereof;
- wherein,
- R1 is H or alkyl;
- R2 and R2′ are each independently H, halogen, alkyl, —OH, or —O-alkyl, or R2 and R2′ together with the atom to which they are attached form a cycloalkyl ring;
- R3 and R3′ are each independently hydrogen, alkyl, —OH, —O-alkyl, or —O-cycloalkyl, or R3 and R3′ together with the atom to which they are attached form an oxo;
- R4, R5, R6 and R7 are each independently hydrogen, halogen, —OH, —O-alkyl, —O-cycloalkyl, alkylene—OR8, —SH, —S alkyl, —S cycloalkyl, or alkylene—SR8, or R5 and R6 together with the atoms to which they are attached form a 5- to 8-membered heterocyclyl ring;
- R8 is H, alkyl, cycloalkyl, or alkylenecycloalkyl;
- X is a cleavable promoiety having the structure
- wherein:
- R9 and R10 are each independently alkyl.
7 more elements
Dependencies are inferred from the claim text.